Malaysian Genomics Resource Centre Bhd
KLSE:MGRC
Malaysian Genomics Resource Centre Bhd
Malaysian Genomics Resource Centre Bhd. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2010-01-25. The company provides genome sequencing and analysis, and genetic screening services. The company offers end-to-end genomics services that comprise genome sequencing, genome analysis, and genetic screening. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. The company offers both de novo sequencing and resequencing as part of its WGS service. Its genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individual’s deoxyribonucleic acid (DNA). Dtect also screens for genetic markers related to adverse reactions towards drugs used in treating certain diseases. The company operates dialysis centers through MGRC Healthcare Sdn Bhd.
Malaysian Genomics Resource Centre Bhd. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2010-01-25. The company provides genome sequencing and analysis, and genetic screening services. The company offers end-to-end genomics services that comprise genome sequencing, genome analysis, and genetic screening. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. The company offers both de novo sequencing and resequencing as part of its WGS service. Its genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individual’s deoxyribonucleic acid (DNA). Dtect also screens for genetic markers related to adverse reactions towards drugs used in treating certain diseases. The company operates dialysis centers through MGRC Healthcare Sdn Bhd.
